July 8, 2020— New bipartisan legislation introduced by six senior members of the U.S. Senate would protect hospitals from losing eligibility for the 340B drug pricing program during the COVID-19 health emergency. The bill (S. 4160) was introduced July 2 by Sen. John Thune (R-S.D.), the majority whip and second-ranking member in the Senate. Thune was joined by five original … [Read more...]
Congress Urged to Loosen Limits on 340B Discounts for Orphan Drugs
June 29, 2020— A pair of researchers is calling on Congress to relax the limitations on 340B price discounts for orphan drugs at safety-net hospitals during the national response to the COVID-19 pandemic. In an opinion piece posted June 25 in Health Affairs, they note that many of the drugs being tested to treat or prevent COVID are considered orphan drugs – meaning they were … [Read more...]
340B Is a Cancer Lifeline for the Underserved
June 25, 2020— Although cancer can sicken and kill people of all races and ethnicities, disability statuses, and socioeconomic levels, it is a documented fact that members of certain underserved populations are more likely to have problems accessing cancer treatments and to have worse health outcomes. It is also a documented fact that hospitals participating in the 340B … [Read more...]
The 340B Program Has a New Podcast
May 18, 2020— If your job requires you to keep up to date on the latest developments in the 340B drug pricing program, 340B Health has a new podcast designed to keep you informed and in touch with the nation’s top 340B experts. 340B Insight launched today featuring an exclusive interview with Rear Admiral Krista Pedley, the leader of the government agency that oversees the … [Read more...]
340B Means Better Diabetes Care
May 8, 2020— The threat of chronic diseases such as diabetes has not taken a break during the nation’s response to the COVID-19 pandemic. More than one in 10 Americans are living with diabetes, with typically underserved populations hit hard not only by the disease but also by the life-threatening complications that can come with it. The pandemic only serves to make the … [Read more...]
Pandemic Highlights Persistent Disparities in Care
April 22, 2020— The COVID-19 pandemic is the latest public health issue to highlight the persistent gaps among different groups of Americans in accessing needed care and attaining their best possible health outcomes. Amid another sobering reminder of these disparities, 340B hospitals continue to focus their missions on serving the underserved. Early reports during the … [Read more...]
340B Data Show How Savings Help Patients with Low Incomes and Protect Access in Rural Areas
April 2, 2020— Results from 340B Health’s annual survey of hospitals confirms the 340B drug pricing program is working the way Congress intended. Surveyed 340B hospitals report using their savings from prescription drug discounts to improve access to care and health outcomes for patients with low incomes and those living in rural communities. Hospital savings go to maintain or … [Read more...]